Abstract:Large Artificial Intelligence (AI) training workloads spanning several tens of thousands of GPUs present unique power management challenges. These arise due to the high variability in power consumption during the training. Given the synchronous nature of these jobs, during every iteration there is a computation-heavy phase, where each GPU works on the local data, and a communication-heavy phase where all the GPUs synchronize on the data. Because compute-heavy phases require much more power than communication phases, large power swings occur. The amplitude of these power swings is ever increasing with the increase in the size of training jobs. An even bigger challenge arises from the frequency spectrum of these power swings which, if harmonized with critical frequencies of utilities, can cause physical damage to the power grid infrastructure. Therefore, to continue scaling AI training workloads safely, we need to stabilize the power of such workloads. This paper introduces the challenge with production data and explores innovative solutions across the stack: software, GPU hardware, and datacenter infrastructure. We present the pros and cons of each of these approaches and finally present a multi-pronged approach to solving the challenge. The proposed solutions are rigorously tested using a combination of real hardware and Microsoft's in-house cloud power simulator, providing critical insights into the efficacy of these interventions under real-world conditions.
Abstract:Clinical monitoring of metastatic disease to the brain can be a laborious and time-consuming process, especially in cases involving multiple metastases when the assessment is performed manually. The Response Assessment in Neuro-Oncology Brain Metastases (RANO-BM) guideline, which utilizes the unidimensional longest diameter, is commonly used in clinical and research settings to evaluate response to therapy in patients with brain metastases. However, accurate volumetric assessment of the lesion and surrounding peri-lesional edema holds significant importance in clinical decision-making and can greatly enhance outcome prediction. The unique challenge in performing segmentations of brain metastases lies in their common occurrence as small lesions. Detection and segmentation of lesions that are smaller than 10 mm in size has not demonstrated high accuracy in prior publications. The brain metastases challenge sets itself apart from previously conducted MICCAI challenges on glioma segmentation due to the significant variability in lesion size. Unlike gliomas, which tend to be larger on presentation scans, brain metastases exhibit a wide range of sizes and tend to include small lesions. We hope that the BraTS-METS dataset and challenge will advance the field of automated brain metastasis detection and segmentation.